Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,137.50    0.00 (0.00%)
Bid:
1,029.00
Ask:
1,184.00
Spread: 155.00 (15.063%)
Market Cap: £4.09b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

Directorate Change

13 Apr 2018 12:52

RNS Number : 9009K
Burberry Group PLC
13 April 2018
 

 

BURBERRY GROUP PLC APPOINTS DR. GERRY MURPHY AS CHAIRMAN DESIGNATE

 

 

The Company is pleased to announce that Dr. Gerry Murphy has been appointed to the Board as Chairman designate.

 

His appointment concludes the process initiated in June 2017 and led by Senior Independent Director Jeremy Darroch to name a successor to Sir John Peace by the end of 2018.

 

Gerry will start on 17 May and will succeed Sir John as Burberry Chairman after the Company's annual shareholder meeting on 12 July. Sir John will step down from the role and from the Board on the same date after 16 years.

 

Gerry is an experienced Chair and senior board member, having served as non-executive director of companies including British American Tobacco plc, Merlin Entertainments plc and Reckitt Benckiser plc.

 

He is currently Chairman of Tate and Lyle plc and of The Blackstone Group International Partners LLP, Blackstone's principal European entity. Before joining Blackstone as a senior managing director in its private equity group, he served as CEO of Kingfisher plc, Carlton Communications, Exel plc and Greencore Group plc.

 

Jeremy Darroch, Senior Independent Director, said:

 

"We are delighted to welcome Gerry to the Board. His substantial UK plc and global business experience will be a great asset to Burberry as we continue to focus on delivering long-term shareholder value."

 

"On behalf of the Board, I would like to thank Sir John for his immense contribution to Burberry over the past 16 years. Sir John has presided over a period of extraordinary change, during which Burberry has enjoyed strong growth and evolved into one of the most valuable luxury brands in the world."

 

Gerry Murphy, Chairman designate, commented:

 

"I am honoured to take up this role and to succeed Sir John as Chairman. Burberry is a unique British brand that I have admired for a long time and I am looking forward to working with Marco Gobbetti and the Board to guide the Company through its next phase of growth."

 

Sir John Peace, Chairman, said:

 

"I would like to thank current and past Board members for their partnership over the past 16 years and Jeremy Darroch for leading the process to find Burberry's next Chairman. In Gerry Murphy, we have found a superb candidate with extensive experience in the consumer and retail industries. I am confident he is the right choice to lead the Board as Burberry embarks on a new chapter."

 

 

13 April 2018

 

Enquiries

 

Investors and analysts

Charlotte Cowley

VP, Investor Relations

020 3367 3524

Charlotte.Cowley@burberry.com

 

Media

Andrew Roberts

 

Louise Hogberg

VP, Corporate Relations

 

Manager, Corporate Relations

020 3367 3764

Andrew.Roberts@burberry.com

Louise.Hogberg@burberry.com

 

 

About Burberry

- Founded in 1856, Burberry is a global luxury brand with a distinctive British identity

- Burberry designs and sources apparel and accessories, selling through a diversified network of retail (including digital), wholesale and licensing channels worldwide

- At 31 December 2017, Burberry globally had 205 retail stores, 199 concessions, 57 outlets and 47 franchise stores

- Burberry is headquartered in London. It is listed on the London Stock Exchange (BRBY.L) and is a constituent of the FTSE 100 index. Its ADR symbol is OTC:BURBY

- BURBERRY, the Equestrian Knight Device and the Burberry Check are trademarks belonging to Burberry that are registered and enforced worldwide

- This announcement does not constitute an invitation to underwrite, subscribe for or otherwise acquire or dispose of any Burberry Group plc shares, in the UK, or in the US, or under the US Securities Act 1933 or in any other jurisdiction.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABBGDSBUBBGIX
Date   Source Headline
10th Jun 20264:52 pmRNSDirector Declaration
9th Jun 202611:30 amRNSHolding(s) in Company
1st Jun 202610:15 amRNSIssue of Shares & Total Voting Rights
28th May 202610:45 amRNSAnnual Financial Report
14th May 20267:01 amRNSBoard changes
14th May 20267:00 amRNSBurberry FY26 Preliminary Results
1st May 202612:20 pmRNSIssue of Shares & Total Voting Rights
29th Apr 20262:45 pmRNSDirector Declaration
10th Apr 20263:40 pmRNSHolding(s) in Company
9th Apr 202611:30 amRNSHolding(s) in Company
1st Apr 20265:30 pmRNSIssue of Shares & Total Voting Rights
1st Apr 202612:15 pmRNSHolding(s) in Company
20th Mar 202612:31 pmRNSDirector/PDMR Shareholding
20th Mar 202610:25 amRNSIssue of Equity
19th Mar 20266:00 pmRNSHolding(s) in Company
5th Mar 20264:40 pmRNSHolding(s) in Company
2nd Mar 202611:00 amRNSTotal Voting Rights
12th Feb 20262:00 pmRNSHolding(s) in Company
10th Feb 202610:30 amRNSHolding(s) in Company
2nd Feb 20262:00 pmRNSTotal Voting Rights
27th Jan 20265:00 pmRNSHolding(s) in Company
22nd Jan 202612:30 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSThird Quarter Trading Update
9th Jan 202612:30 pmRNSHolding(s) in Company
2nd Jan 202611:30 amRNSTotal Voting Rights
18th Dec 20252:01 pmRNSHolding(s) in Company
18th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20259:15 amRNSDirector/PDMR Shareholding
2nd Dec 20255:40 pmRNSHolding(s) in Company
1st Dec 20251:30 pmRNSTotal Voting Rights
24th Nov 20255:30 pmRNSHolding(s) in Company
20th Nov 20254:20 pmRNSHolding(s) in Company
19th Nov 20255:36 pmRNSHolding(s) in Company
18th Nov 20256:07 pmRNSHolding(s) in Company
13th Nov 20255:27 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNSBurberry Interim Results
3rd Nov 20252:43 pmRNSTotal Voting Rights
28th Oct 20254:50 pmRNSHolding(s) in Company
15th Oct 20255:38 pmRNSHolding(s) in Company
10th Oct 202512:07 pmRNSHolding(s) in Company
2nd Oct 20253:10 pmRNSHolding(s) in Company
1st Oct 202510:30 amRNSTotal Voting Rights
25th Sep 20256:00 pmRNSHolding(s) in Company
5th Sep 20256:21 pmRNSBlock listing Interim Review
5th Sep 20255:45 pmRNSDirector/PDMR Shareholding
1st Sep 202512:14 pmRNSTotal Voting Rights
13th Aug 20253:04 pmRNSHolding(s) in Company
1st Aug 202511:58 amRNSTotal Voting Rights
31st Jul 20254:55 pmRNSDirector/PDMR Shareholding
18th Jul 20255:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.